BOFFA, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 3.658
AS - Asia 19
NA - Nord America 2
SA - Sud America 1
Totale 3.680
Nazione #
IT - Italia 3.658
CN - Cina 17
SG - Singapore 2
US - Stati Uniti d'America 2
EC - Ecuador 1
Totale 3.680
Città #
Genoa 1.924
Genova 904
Vado Ligure 494
Rapallo 332
Beijing 11
Bordighera 4
Ashburn 2
Singapore 2
Huaquillas 1
Totale 3.674
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 170
A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb 168
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 162
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 150
Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes” 137
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 132
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 128
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 121
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis 118
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 109
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 102
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 102
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 97
Impact of highly active immunotherapy on acute and chronic neuroinflammation in aggressive multiple sclerosis 96
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 93
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 93
Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis 85
Clinical and radiological correlates of apathy in multiple sclerosis 82
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 82
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases 82
Long-term clinical outcomes of hematopoietic stem cell transplantation in multiple sclerosis 81
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis 76
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 74
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 71
An aggressive form of MOGAD treated with aHSCT: A case report 67
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 67
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 67
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis 67
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 67
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions 65
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 62
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 62
The effect of Cladribine and Fingolimod treatments on retinal atrophy 60
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 59
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis 55
Positron Emission Tomography with [18F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression 53
What happens after fingolimod discontinuation? A multicentre real-life experience 44
HSCT for stiff person syndrome and myasthenia gravis 41
Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes 39
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 38
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 38
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 36
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury 34
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 34
Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury 31
Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice 25
Markerless Video-based Gait Analysis in People with Multiple Sclerosis 21
null 20
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation 12
E200k familial creutzfeldt-jakob disease presenting with subacute multiple cranial neuropathy 10
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod 8
Totale 3.793
Categoria #
all - tutte 16.938
article - articoli 16.518
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 131
Totale 33.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 48 15 18 7 20 18 24 11 11
2021/2022250 13 4 7 19 8 21 3 59 22 39 12 43
2022/2023407 31 36 5 48 36 55 2 25 54 20 77 18
2023/2024513 20 34 11 53 33 91 120 20 20 23 29 59
2024/20251.268 82 95 58 73 149 118 95 223 81 63 127 104
2025/2026640 289 67 167 117 0 0 0 0 0 0 0 0
Totale 3.793